What's the chance that somebody who was exposed to radiation now has a subsequent cancer later on in their life? The chance of that is a statistical one, meaning there's no large study out there where people are followed for hundreds of months. Researchers have looked at young women who had breast cancer in the [...]
Radiation is high energy x-rays. When you are depositing energy into a target with the latest technology, you're able to kill off a tumor and you're able to preferentially address a given region and to spare the adjacent tissues around that region. There are different types of radiation, but therapeutic radiation is high dose [...]
Taking care of a loved one can be a rewarding but stressful experience. You may feel that you are the best equipped to handle the situation, or financial concerns may have prodded you unwittingly into the caregiver role. No matter how prepared you may be for the job, caregiver stress can plague anyone. This [...]
Being told that you have prostate cancer may be one of the most stressful events that occur in your lifetime. After a cancer diagnosis, you may be overwhelmed, worried about what happens next, or thinking about its impact on your life. The many emotions that follow a prostate cancer diagnosis make a major impression [...]
Malecare's collection of emotion crisis resources. Call these, even if you don't know if you "really" need them. Many international calls are free or affordable with SKYPE and many other apps. Feel OK about calling resources outside of your country. US: Hopeline (Suicide Prevention): 1-800-SUICIDE (1-800-784-2433) US: Suicide Hotline: 1-800-273-Talk (1-800-8255) UK: Samaritans (Nat’l [...]
Agent Orange is usually the first thing veterans with prostate cancer ask about. Indeed, way back in 1998, Malecare was an early advocate for men exposed to Agent Orange. Military veterans as well as Vietnamese, Cambodian and Laotian civilians were exposed to Agent Orange, and many of those who are men are now diagnosed, [...]
Prostate cancer patients struggle to ask all of their questions. Men often leave their doctor's offices with one or more unanswered question...."I forgot to ask." Even with lists of questions written out in advance, patients skip over one or more questions or simply fail to give voice to things that trouble them the [...]
Erleada (apalutamide) has just received FDA approval as a drug for treating men with non-metastatic castration-resistant prostate cancer. The proper pronunciation is Er ( Errr), (Like Her without the h) ) (lee) (long E) da. Now, repeat after me, "Erleada!" It's a pill that you take - I believe - four times a [...]
Non-Metastatic Castrate Resistant Prostate Cancer (nmCRPC) usually leads to metastatic prostate cancer and death. There are no approved treatments for nmCRPC. Apalutamide is a taken-by-mouth androgen receptor inhibitor with antitumor activity in CRPC. There's a much talked and written about clinical trial called, SPARTAN, that investigated how well Apalutamide works on maintaining metastasis-free survival (MFS) [...]
Non-metastatic Castrate Resistant prostate cancer patients take note. The Phase 3 PROSPER trial in patients with non-metastatic (M0) Castration-Resistant Prostate Cancer (CRPC) showed that the use of XTANDI® (enzalutamide) plus androgen deprivation therapy (ADT) significantly reduced the risk of developing metastases or death by 71 percent compared to ADT alone. It will be a [...]
